Introduction
Primary infection with human immunodeficiency virus (HIV) has been defined by the Centers for Disease Control (CDC) as a mononucleosis-like illness, with or without aseptic meningitis, associated with seroconversion for HIV antibody.'
Since the introduction of this definition in 1986, it has become clear that symptomatic primary human immunodeficiency virus type 1 (HIV-1) infection can be a recognisable clinical syndrome with distinct differences from Epstein-Barr virus (EBV) infectious mononucleosis. Moreover, the CDC definition does not encompass the full clinical spectrum of primary HIV-1 infection.
We will outline the syndrome of primary infection with HIV-1 by reviewing clinical, virological and immunological features. Differential diagnostic considerations will also be discussed.
Clinical findings
Primary infection with HIV-1 is symptomatic in the majority of cases. An acute clinical illness during the period of seroconversion has been reported with an incidence ranging from 53 to 93% of patients.2`The time from infection with HIV-1 to the onset of clinical illness seems to vary between 1 and 4 weeks for the mononucleosis-like illness, and up to 6 weeks for neurological symptoms.3 [7] [8] [9] [10] [11] [12] [13] [14] The duration of the illness ranges from a few days to 2 months, depending on the severity of symptoms.3 59 15 A duration of more than 14 days seems to predispose to an early progression of HIV-1 infection to AIDS. 4 Symptomatic primary infection with HIV-1 is most commonly described as an influenza-or mononucleosis-like illness of varying severity. Although a Department of Internal Medicine, AIDS-unit MD Since CD8 + levels remain higher than CD4 + levels, the inverted CD4 + /CD8 + ratio persists.
Early signs of a host response to primary HIV-1 infection include a transient appearance of interferon-alpha in the blood and raised levels of neopterin and beta2-microglobulin.i Initially increased beta2-microglobulin levels correlate with the rate of decline of CD4 + cell counts in the ensuing years.
Differential diagnosis A diagnosis of primary HIV-1 infection should be considered in any person presenting with an acute febrile illness who belongs to a risk group for HIV infection or has a history of possible recent exposure to HIV. In a prospectively studied group of homosexual men, primary HIV infection was the second most frequent cause (after influenza) for an acute febrile illness lasting more than three days.'M The index of suspicion for a diagnosis of primary HIV-1 infection is increased when the patient complains of a sore throat, myalgia, arthralgia, headaches, diarrhoea or neurological symptoms and physical examination shows a maculopapular rash, mucocutaneous ulceration or lymphadenopathy.
Although the clinical presentation of primary HIV-1 infection as described above is quite distinct, several differential diagnoses should be considered (table 3) . Dermatological manifestations of primary HIV-1 infection are valuable diagnostic signs. Since the maculopapular rash in secondary syphilis is very similar to the HIV exanthem and the patients history often reveals high risk sexual behaviour, secondary syphilis is the most important dermatological differential diagnosis. Differentiation will be possible by serological testing for syphilis and HIV.
Lesions in pityriasis rosea greatly resemble those seen in primary HIV-1 infection. However, pityriasis rosea is mainly distributed over the trunk and upper extremities and often begins with a solitary herald patch, followed by the exanthem in 5-15 days. Moreover, constitutional symptoms are mild or absent in pityriasis rosea and there may be mild to moderate pruritus.
CMV and toxoplasma infections are usually not associated with an exanthem. In rubella the palms and soles are not affected. In patients using medication, especially antibiotics, a drug eruption should be included in differential diagnosis. The previously described mucocutaneous ulceration in primary HIV-1 infection is an unusual finding in most other diagnoses and may aid in differentiation.
As is suggested by the CDC definition, the clinical features of EBV infectious mononucleosis and primary HIV-1 infection are similar. However, there are some distinct differences which may enable differentiation. 65 In infectious mononucleosis, the onset of the illness is insiduous rather than acute. Although a sore throat is a common complaint in both illnesses, examination of the throat in infectious mono- Clinical recognition ofprimary infection with HIV is of importance in controlling the spread of the AIDS epidemic, since counselling efforts to limit spread of the infection can be made at an early stage of HIV infection. Early monitoring of infected persons may be ofimportance in optimal targetting of antiretroviral therapeutic intervention. Controlled studies are needed to assess the value of zidovudine in the treatment of primary HIV infection.
